ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 128

Frequency Of Axial Spondyloarthropathy Among Patients Suffering From Fibromyalgia A Magnetic Resonance Immaging  Study With Application Of The Assessment Of Spondylo-Arthritis International Society Classification Criteria

Jacob N. Ablin1, Iris Eshed2, Valerie Aloush1, Irena Wigler3, Dan Caspi1, Maria Likhter4, Mark Berman5, Yonatan Wolman1, Daphna Paran6, Marina Anouk7 and Ori Elkayam8, 1Rheumatology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel, 2Department of Radiology, Sheba Medical Center, Tel Hashomer, Israel, 3Department of Rheumatology, Tel Aviv Sourasky Medical Center and the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel, 4Internal Medicine 6, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel, 5Internal Medicine F, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel, 6Rheumatology, Tel Aviv Sourasky Medical Ctr, Tel-Aviv university, Tel Aviv, Israel, 7Rheumatology, Tel Aviv Sourasky Medical Ctr, Tel-Aviv University, Tel Aviv, Israel, 8Rheumatology, Tel-Aviv Medical Center, Sackler Faculty of Medicine, Tel-Aviv University, Tel- Aviv, Israel

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: ankylosing spondylitis (AS) and fibromyalgia, MRI

  • Tweet
  • Email
  • Print
Session Information

Title: Fibromyalgia, Soft Tissue Disorders and Pain I

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Fibromyalgia Syndrome (FMS), considered the result of increased processing of pain by the central nervous system, is a non-inflammatory condition characterized by chronic, widespread musculoskeletal pain and tenderness.

Axial spondyloarthritis (SpA) is the hallmark of Ankylosing Spondylitis (AS), an inflammatory joint disease primarily involving the sacroiliac joints and axial spine. Although FMS and axial SpA differ vastly in their pathogenesis, a considerable clinical overlap may exist between these conditions. Chronic nocturnal back pain and disturbed sleep may accompany either condition. We have previously described an increased prevalence of (secondary) FMS among female AS patients. The Assessment of Spondylo-Arthritis international Society (ASAS) has published updated classification criteria for axial SpA. These criteria are based on the evaluation of patients suffering from chronic back pain with an age of onset of less than 45.

Objective: To evaluate the prevalence of axial SpA among FMS patients, utilizing the 2010 ASAS criteria (1).

Methods: Patients suffering from FMS (ACR 1990 classification criteria) were recruited consecutively from a specialized FMS clinic. Patients were interviewed regarding the presence of SpA features, as defined by the ASAS group (Inflammatory back pain, arthritis, enthesitis, uveitis, dactylitis, psoriasis, Crohn’s / colitis, good response to NSAIDSs, family history of SpA) and underwent HLA-B27 testing and CRP measurement. MRI examinations of the sacro-iliac joints were performed on a 1.5 T MRI unit using semicoronal T1-weighted, STIR and FSPGR pre- and post-contrast injection sequences. FMS severity was assessed by the FIQ and SF-36 questionnaires and physical examination of the tender points using a dolorimeter. SpA symptom severity was assessed by the BASDAI questionnaire 

Results:

61unselected patients were recruited and MRI results were available for 56.

Table 1 summarizes MRI findings, HLA-B27 results and ASAS criteria positivity among FMS patients (N=56):

Sacroiliitis (2)

Erosions

Sub-chondral  sclerosis

Fatty replacement

HLA-B27

ASAS criteria positive

4 (7.1%)

11 (19.6%)

12 (21.4%)

4 (7.1%)

3(5.4%)

4(7.1%)

Sacroiliitis, based on ASAS definition (2), was found among 4 patients, 3 of which fulfilled ASAS SpA criteria. One additional patient fulfilled SpA criteria based on HLA-B27 positivity and additional SpA features.

Conclusion:

Imaging changes suggestive of inflammatory SpA were common among patients presenting with a clinical diagnosis of FMS. Definite sacroiliitis and ASAS criteria SpA positivity were diagnosed among 7.1% of patients and additional changes typical of SpA were frequent. These findings suggest that FMS may mask an underlying SpA, a diagnosis with important therapeutic implications. Thus, physicians involved in the management of FMS should remain vigilant to the possibility of underlying inflammatory disorders and actively search for such co-morbidities.

Ref.

1. Sieper J et al. Ann Rheum Dis 2009;68:8(Suppl II):ii1–ii44

2. Rudwaleit M et al. Ann Rheum Dis 2009; 68(10):1520


Disclosure:

J. N. Ablin,

Pfizer Inc,

8;

I. Eshed,
None;

V. Aloush,
None;

I. Wigler,
None;

D. Caspi,
None;

M. Likhter,
None;

M. Berman,
None;

Y. Wolman,
None;

D. Paran,
None;

M. Anouk,
None;

O. Elkayam,
None.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/frequency-of-axial-spondyloarthropathy-among-patients-suffering-from-fibromyalgia-a-magnetic-resonance-immaging-study-with-application-of-the-assessment-of-spondylo-arthritis-international/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology